Opportunities and challenges in stem cell therapy in cardiovascular diseases: Position standing in 2022-Reference-Cited by-同舟云学术

Opportunities and challenges in stem cell therapy in cardiovascular diseases: Position standing in 2022

Published:2022-09 Issue:9 Volume:30 Page:1360-1371
ISSN:1319-0164
Container-title:Saudi Pharmaceutical Journal
language:en
Short-container-title:Saudi Pharmaceutical Journal

Author:

Mahmud Shabnur,Alam Safaet,Emon Nazim Uddin,Boby Umme Habiba,Kamruzzaman ,Ahmed Firoj,Monjur-Al-Hossain A.S.M.,Tahamina Afroza,Rudra Sajib,Ajrin Marzina

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference90 articles.

1. Silver nanoparticles induce the cardiomyogenic differentiation of bone marrow derived mesenchymal stem cells via telomere length extension;Adibkia;Beilstein J. Nanotechnol.,2021

2. Arrhythmia in stem cell transplantation;Almeida;Cardiac Electrophysiol. Clinics,2015

3. Autologous skeletal myoblast patch implantation prevents the deterioration of myocardial ischemia and right heart dysfunction in a pressure-overloaded right heart porcine model;Araki;PLoS ONE,2021

4. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy;Assmus;J. Am. Coll. Cardiol.,2010

5. Human cardiac stem cells;Bearzi;Proc. Natl. Acad. Sci.,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics;Advanced Drug Delivery Reviews;2024-05

2. To Repair a Broken Heart: Stem Cells in Ischemic Heart Disease;Current Issues in Molecular Biology;2024-03-08

3. Application and challenges of stem cells in cardiovascular aging;Regenerative Therapy;2024-03

4. Exosomal Cargo: Pro-angiogeneic, anti-inflammatory, and regenerative effects in ischemic and non-ischemic heart diseases – A comprehensive review;Biomedicine & Pharmacotherapy;2023-12

5. PROSPECTS FOR THE USE OF UMBILICAL CORD BLOOD IN THE TREATMENT OF DISEASES OF THE CARDIOVASCULAR SYSTEM;Biotechnologia Acta;2023-08-31